Michael Li, MD, MPH
@michaellimd
Transplant hepatologist @UCSF studying cancer and autoimmune liver disease | @UCSFTransplant @BrighamGI @HarvardChanSPH @IcahnMountSinai @BrownUniversity alum
ID: 1328082126923821059
15-11-2020 21:07:28
64 Tweet
202 Followers
120 Following
Congratulations to Dr. Walter Chan (Walter Chan, MD, MPH), our Director of the Center for GI Motility & Director of Clinical Research Education, for his #promotion to Associate Professor of Medicine at Harvard Medical School Harvard Medical School 🍾 #BWHMotility #BrighamGIFaculty #BrighamGIAlum
I'm so honored to receive an ACG Junior Faculty Development Award to study outcomes of HCC immunotherapy! Many thanks to my amazing co-mentors Jen Lai and Larry Fong and my UCSF Transplant and UCSF Helen Diller Family Comprehensive Cancer Ctr collaborators for their support. #ACGInstitute #livertwitter
Huge congrats to UCSF IM resident and (hopefully) future hepatologist Melinda Wang for receiving an ACG Medical Resident Research Award to study the effects of Stelara in PSC. So excited to work with you on this study and many more! #livertwitter UCSF IM Chiefs
This #WomensHistoryMonth, we're honored to highlight Monika Sarkar, NIH-funded researcher in women's reproductive health and NAFLD and Chair, AASLD Women's Initiatives Committee. #LiverTwitter #WHM Norah Terrault
From the newest members of our amazing group to the leaders at the top, my work family inspires greatness. Jessica Rubin Giuseppe Cullaro Jin Ge Monika Sarkar Michael Li, MD, MPH UCSF Liver Center UCSF Transplant
Research by Melinda Wang emphasizes the complexity of symptoms PSC patients experience & highlights the importance of considering these symptoms in clinical trials and future research. Learn more about why this research received a 2023 Abstract Award at aasldfoundation.org
Incredibly honoured to attend #TLM23 as an Emerging Liver Scholar! Thank you so much Guadalupe GarciaTsao and AASLD Foundation for the opportunity and for those who welcomed me to the community! 🌟struck and inspired to help improve liver related care! AASLD #LiverTwitter
Congrats Melinda Wang! So happy that you’re staying, looking forward to working with you as a fellow!
Patients want to be in clinical trials but are rarely asked And - key point - if your trial seeks to help them FEEL better, they really want to be asked This study in Hepatology Communications from Michael Li, MD, MPH is about PSC but the message is universal journals.lww.com/hepcomm/fullte…
Check out our review of immunotherapy in HCC with a focus on its role in expanding access to curative liver transplantation, now out in Journal of Hepatology. It was amazing working with Vincenzo Mazzaferro and Neil Mehta in this joint San Francisco-Milan effort! journal-of-hepatology.eu/article/S0168-…
Michael Li, MD, MPH et al found that outcomes of high-grade immune checkpoint inhibitor hepatitis were similar in hospitalized and non-hospitalized patients, suggesting that not all patients with high ALT levels need to be hospitalized ow.ly/3qLG50SyXlI
Immunotherapy for hepatocellular carcinoma ➡️The next evolution in expanding access to liver transplantation Full text here👉journal-of-hepatology.eu/article/S0168-… Michael Li, MD, MPH Sherrie Bhoori #LiverTwitter
Apply for the #ACGInstitute Clinical Research Leadership Program! Learn research leadership skills to maintain a successful independent research program. For US physician members 2-15 years post-fellowship. Apply by November 15 ➡️ gi.org/crlp #CRLP Neena S Abraham MD MACG FASGE AGAF
🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️ ✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data Full text👉bit.ly/3VKZmcy #CPGs #LiverTwitter EASLnews EASL Education Aleksander Krag
For anyone attending #NCCN2025 in Orlando, I'm excited to be speaking during the immune checkpoint inhibitor toxicities session tomorrow (Friday 3/28). Looking forward to talking about immune-mediated hepatitis with an oncology audience! National Comprehensive Cancer Network (NCCN) UCSF Helen Diller Family Comprehensive Cancer Ctr #livertwitter
